New invasive procedures may help patients with chronic refractory headache

Cluster headache has a substantial detrimental effect on quality of life. New invasive procedures, such as hypothalamic deep brain stimulation and bilateral occipital nerve stimulation, may help patients with chronic refractory headache. This is one of the conclusions reached by Charly Gaul and co-authors from the Department of Neurology at the University Medical Center Essen in the current issue of Deutsches Ärzteblatt International.

Cluster headache is the commonest trigemino-autonomic headache, affecting some 120,000 people in Germany. Typically, patients suffer unilateral short attacks, which are accompanied by restlessness. The causes of cluster headache are not clear. Men are affected more often than women, with a ratio of 3.5:1.

Treating the pain attacks with trioptans or inhalation of pure oxygen is effective and well supported by scientific evidence. According to the authors, verapamil is the medication of choice for the purpose of prophylaxis, with onset of effectiveness within the first week. Lithium is an alternative, especially for treating chronic disease.

Source:

Deutsches Ärzteblatt International

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neurodivergent children face higher risk of chronic disabling fatigue by 18, study finds